Contribute Try STAT+ Today

Call it a one-two punch.

At the same time California Governor Jerry Brown signed a law, requiring drug makers explain and justify price hikes, he also signed another law prohibiting the use of prescription drug coupons when a lower-priced generic medicine is available.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • I currently take Rapaflo only because the low priced generic called FloMax gave me several unwanted side effects. In fact, it worsened my condition. Previously, I was able to use a manufacturers coupon for Rapaflo which lowered the cost. Now, thanks to our legislators in California’s, I pay over $300 monthly. Any help for me?

  • I kept waiting for this article to address the most important detail of this bill – what is considered an “alternative”? If there is a generic version of the molecule available, that’s a no-brainer. However if you are Rx’d a brand name antihypertensive for which no generic of that specific molecule exists, does the law mandate you can’t use a co-pay coupon since you could be taking a generic of a different antihypertensive in the same class (like a beta blocker for instance). If that’s the case, I think this bill is ill-advised.
    Another example – what if a patient is Rx’d an extended release version of a molecule which is only available as a brand, however there is an immediate release version of that molecule available as a generic. No co-pay coupon? If that’s the case, again I think this is not a good idea.
    As usual, the details matter.

    • Hi TW,

      Thanks for the note and you ask a good question. The law does not get into the level of detail as you frame it, but does say a coupon cannot be used for a drug if a another that therapeutically equivalent to, or interchangeable
      is available. To use your example, extended release and immediate release drugs work differently and therefore are prescribed for different reasons and are not generally considered interchangeable.

      On the other hand, if one is prescribed a drug and another in the same class is lower cost, then a coupon could not be used. The law says that a coupon cannot be used “if a lower-cost brand name or nonbrand name prescription drug is available that is designated by the United States Food and Drug Administration as therapeutically equivalent to, or interchangeable with” the drug to be prescribed.

      I included a link to the law in the story, so you can read the language. In any event, I hope this helps.

      ed at pharmalot

Comments are closed.